Database ranks 50,000 processed foods

Research analyzes over 50,000 food products, highlighting the dominance of ultra-processed options in grocery stores and its implications for public health.

Trastuzumab duocarmazine by Byondis for Gastric Cancer: Likelihood of Approval

Trastuzumab duocarmazine is under clinical development by Byondis and currently in Phase I for Gastric Cancer.

February 9, 2024

California Cannabis Company StateHouse Sees Q4 Revenue Decline 17%…

StateHouse Reports Fourth Quarter and Year-End 2022 Financial Results FY 2022 revenue increased 80% to $108.2 million with a 62% improvement in annual gross profit

May 5, 2023

Everyday physical activity alone not enough to prevent stroke

Research conducted at the University of Gothenburg shows that the physical activities we do as we go about our lives, at work or in the

July 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.